Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
President Donald Trump, who once declared he had “saved” flavored vapes, grew his stock holdings…
Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
President Donald Trump, who once declared he had “saved” flavored vapes, grew his stock holdings this year to as much as $1.64 million in tobacco giant Philip Morris. He also had holdings in Altria and a third leading tobacco company, though an apparent discrepancy in his disclosures clouds the extent of his investments. In 2025,…
The Long and Winding Road: 75 Years of Competition in Health Care Policy
When health economics emerged as a distinct discipline in the late 1960s, mainstream academic and policy paradigms widely presumed that competitive market mechanisms were structurally incompatible with medical delivery. Influenced by foundational ideas like Kenneth Arrow’s 1963 landmark paper emphasizing the pervasive friction of clinical uncertainty, early experts argued that society had to look almost…
DiMe Launches New Initiative for Virtual-First Care
The Digital Medicine Society launched an initiative to help payers and virtual care providers avoid common contract implementation challenges. The post DiMe Launches New Initiative for Virtual-First Care appeared first on MedCity News.
‘2030 Scares Me to Death’: Credit Analysts’ Urgent Warning for Healthcare CFOs
During a panel at HFMA’s annual conference, two healthcare credit analysts said the industry is already fracturing into winners and losers. And with 2030 bringing a perfect storm of demographic pressure, reimbursement cuts and AI disruption, they think window for bold action is closing fast. The post ‘2030 Scares Me to Death’: Credit Analysts’ Urgent…
House Appropriations Committee Releases FY 2027 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bill & Accompanying Report
This budget summary provides an analysis of global health funding amounts provided in the FY 2027 House Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill and accompanying report.
Parabilis Medicines’ Quest to Drug the Undruggable Picks Up $745M From Upsized IPO
Parabilis Medicines is developing a new type of peptide drug capable of hitting elusive disease targets inside cells. Cancer is the biotech’s initial focus, and the IPO cash will support a lead program zolucatetide, which is in development for a rare type of tumor with limited treatment options. The post Parabilis Medicines’ Quest to Drug…
FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen
Officials, environmental health advocates, and skin care industry groups are expressing hope that the Food and Drug Administration’s approval of a sunscreen ingredient on June 9 — after consideration for two decades, and global use for nearly as long — will help restore Americans’ wavering faith in sunscreen. “Bemotrizinol has been used safely in Europe…
Restoring the Patient-Clinician Relationship to the Center of Care
The next evolution of patient experience will not be defined by more digital touchpoints. It will be defined by giving nurses and care teams the capacity to be fully present. The post Restoring the Patient-Clinician Relationship to the Center of Care appeared first on MedCity News.
From Detection to Defense: Building Fraud-Resilient Healthcare Payment Systems
Prevention requires more than faster detection. Organizations need payment programs with end-to-end visibility and controls that intervene before losses occur. The post From Detection to Defense: Building Fraud-Resilient Healthcare Payment Systems appeared first on MedCity News.
The Healthcare Payments Industry Has a Perception Problem
[Sponsored] Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. The post The Healthcare Payments Industry Has a Perception Problem appeared first on MedCity News.
